Atlas Trials

Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism

Clinical trial NCT05814770 · UNKNOWN

Trial details

NCT number
NCT05814770
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Primary AldosteronismHypertension
Start date
2023-05-01
Primary completion
2025-03-01
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.